Image (Image 01)
Diltiazem Hydrochloride Capsule, Extended Release
Product Images NDC 68788-7870
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Diltiazem Hydrochloride (NDC 68788-7870). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (Image 02)
This is a description of a study on the adverse reactions of Diltiazem hydrochloride extended-release capsules. The study compares the reactions of those taking the capsules with those taking a placebo. The study shows the percentage of patients experiencing reactions, such as headache, dizziness, bradycardia, AV block, first-degree, edema, and asthenia.*
Image (Image 04)
Diltazem Hydrochloride Extended-release Cap Usp 120mg (Image 05)
Description: This is a product label for Diltiazem Hydrochloride Extended-Release Capsules in 120mg and 130mg strengths. It contains information related to the product's manufacturer, batch number, and expiration date.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
